Skip to page content

Global Health

Featured

Nations throughout the world face ongoing challenges when it comes to health care quality, costs, delivery, and access; disease prevention; and public health preparedness. RAND analyzes these global health issues and offers recommendations to help governments, health organizations, and other stakeholders arrive at better outcomes.

Report

COVID-19 'Vaccine Nationalism' Could Cost $1.2 Trillion a Year

Oct 28, 2020

Nationalistic behavior by governments may exclude some countries from access to COVID-19 vaccines. This could cost the world economy up to $1.2 trillion a year in GDP. A globally coordinated effort to fight the pandemic is key, not only from a public health perspective but also an economic one.
Commentary

Needed: A Blueprint for a Post-Vaccine World

May 11, 2020

When a COVID-19 vaccine is developed, many in rich countries may be able to afford it while the poor and uninsured may not. The time to plan for equitable access, financing, intellectual property rights, and global production is now.

Explore Global Health

Multimedia

Addressing Vaccine Hesitancy with Research

RAND senior physician policy researcher Courtney Gidengil reveals the biggest driver behind the hesitancy to receive the COVID-19 vaccine.

Jul 26, 2022
Journal Article

Implementation of South Africa's Central Chronic Medicine Dispensing and Distribution Program for HIV Treatment: A Qualitative Evaluation

Participants had highly favorable attitudes about the Chronic Care and Medicine Dispensing and Distribution (CCMDD) program for HIV treatment. Patient-level barriers to care included inadequate education about CCMDD and inability to get refills. Organizational-level barriers included challenges with communication and transportation, errors in medication packaging and tracking, rigid rules, and inadequate infrastructure.

Jun 23, 2022
Commentary

America Can Still Deliver on Global Vaccine Diplomacy

It is hard to see how science alone can end the pandemic without the rallying power of global diplomacy. The United States has played a leadership role in previous outbreaks, such as Ebola. It could play a similar role now to help consign the current pandemic to epidemic status.

Dec 28, 2021
Blog

U.S. 'Entanglement,' Global Health Cooperation, Community Stress: RAND Weekly Recap

This weekly recap focuses on competing claims about U.S. partnerships and allies, responding to Russia's tactics in Ukraine, helping communities recover from stress, and more.

Nov 26, 2021
Commentary

Global Health Data Sharing: The Case of China and the Two Coronavirus Pandemics

Tensions over the coronavirus seem to be prompting China to isolate itself in terms of data sharing. But the first coronavirus pandemic in 2003 actually helped open China to health collaborations with other countries. World leaders may be doing their citizens a disservice when they allow toxic geopolitics to undercut trust and international collaborations that took decades to build.

Nov 22, 2021
Report

Most U.S. Drug Shortages Appear to Be Domestic in Scope

Major U.S. drug shortages are rarely associated with volume and price changes in other countries. A global perspective is important when addressing shortages, but policymakers and the health care system should explore ways to leverage the supply of drugs in other countries in response to U.S. shortages.

Oct 27, 2021
Journal Article

What If Progress Meant Well-Being for All? U.S. Innovators Use Global Insights to Shift the Narrative and Surface Opportunities Ahead

In many countries, progress is sharply defined only as economic growth. What if that narrative shifted and progress were defined as well-being for all people?

Sep 1, 2021
Commentary

Split-Screen Pandemic Recovery Isn't Sustainable

In a world connected by commerce and the air we breathe, it's hard to see how any COVID-19 recovery that's confined to specific segments of the population is sustainable. Failing to address gaps in the pandemic response would run the risk that a future mutation of this virus could send us scurrying for cover. Again.

Jul 20, 2021
Blog

Vaccine Hesitancy, Working from Home, Arctic Diplomacy: RAND Weekly Recap

This weekly recap focuses on vaccine hesitancy as a symptom of ‘Truth Decay,’ how to make remote work beneficial for all, U.S. Arctic diplomacy, and more.

May 21, 2021
Commentary

Vaccine Patents Debate Risks Becoming a Sideshow

As COVID-19 cases continue to surge around the world, the debate is raging over whether patents on existing vaccines should be waived. But the global community could view patent waivers as just one of many available tools for speeding up vaccine delivery worldwide.

May 17, 2021
Commentary

America Could Do More to Get the World Vaccinated

After waging its own withering battle with COVID-19, the United States appears to be coming to grips with the pandemic and its economy is recovering. Now could be the time for America to play a greater role in global vaccination, both out of generosity and self-interest.

May 4, 2021
Blog

Biden's First Address to Congress: Insights from RAND

President Joe Biden addressed a joint session of Congress, summarizing his administration's early COVID-19 response and outlining plans that aim to loosen the pandemic's year-long grip on a weary nation. The speech reflected the fact that the United States faces policy challenges across a wide range of domains.

Apr 29, 2021
Report

Measures and Methodology for International Comparisons of Health Care System Performance: Final Report

RAND researchers worked with 15 experts in quality measurement, clinical care, and health economics to generate potential measure constructs that could improve the U.S. ability to learn from international comparisons of health system performance.

Feb 24, 2021
Commentary

Equal, Rapid Access to Vaccines Is More Important Than Ever as New COVID-19 Variants Emerge

Vaccine nationalism could prolong the pandemic and lead to preventable deaths. If some countries don't receive timely access to vaccines, then the virus will continue to spread in some populations, mutate further, and potentially render existing vaccines less effective.

Feb 9, 2021
Commentary

Vaccine Nationalism Has Real Economic Consequences

Vaccine nationalism, in which countries prioritize their domestic needs at the expense of others, will have significant global economic consequences. Major economies actually have more to gain by helping to make an effective COVID-19 vaccine widely available globally.

Dec 30, 2020
Journal Article

Reflections on the 7th International Jerusalem Conference on Health Policy in the Wake of the Covid-19 Outbreak

In 2019, a conference in Israel showcased new frontiers in technology in healthcare, highlighting research conducted in Israel as well as across the globe.

Dec 30, 2020
Research Brief

The economic benefits of equitable global access to COVID-19 vaccines

Researchers used a global macroeconomic model to examine the economic effects of vaccine nationalism. This brief highlights the cost to 30 high-income countries if low and middle-income countries miss out on initial access to COVID-19 vaccines.

Dec 17, 2020
Research Brief

Unequal Access to COVID-19 Vaccines Would Further Damage the Global Economy

As long as the coronavirus is not under control in all regions of the world there will continue to be a global economic cost associated with COVID-19. Vaccine nationalism could cost up to $1.2 trillion a year in GDP. If the poorest countries cannot access vaccines, the loss would be between $60 and $340 billion a year.

Nov 5, 2020
Multimedia

RAND Remote Series: Tackling an Evolving Pandemic

In this video conversation, Jennifer Bouey discusses RAND's rapid COVID-19 response, including insights and analysis to help strengthen and safeguard communities, rethink and retool institutions, and determine the best ways forward.

Oct 22, 2020

1
2
3
4
5
6
7
8
9
10
Next

RAND Topic:
Global Health

Topic Synonyms:
Global Health Environment

Research conducted by